Allergan Announces Retirement of Board Member Ronald M. Cresswell.IRVINE, Calif. -- Allergan, Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) today announced that, for personal health reasons, Ronald M. Cresswell has retired as a director of Allergan, effective July 9, 2004. "Since joining Allergan's Board of Directors in 1998, Professor Cresswell has been an invaluable and insightful director, blessing Allergan's Board with his excellent judgment, healthcare industry knowledge, and pharmaceutical research and development expertise," said David E.I. Pyott, Allergan's Chairman of the Board, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Professor Cresswell will be deeply missed by Allergan's Board, and I am grateful for his service." About Allergan, Inc. Allergan, Inc., with headquarters in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator, skin care and other specialty markets that deliver value to its customers, satisfy unmet un·met adj. Not satisfied or fulfilled: unmet demands. medical needs, and improve patients' lives. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion